A clinical supply forecast is never static. Learn how to turn changing demand, constrained supply, and uncertainty into decisions that protect inventory and study continuity.
- AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
- Segregation Of Duties: Drug Accountability Needs Three Separate Roles
- When Clinical Demand Becomes A Supply Plan
- Before The Excursion: The Governance Decisions That Should Already Be Made
- Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
ON-DEMAND WEBINARS
Join patient-centric supply chain expert Marco Hogenboom for a discussion on how to accelerate the delivery of advanced therapies in an unpredictable environment through supply chain customization from clinical to commercialization.
Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
Discover how to transform logistical challenges into strategic advantages with flexible, forward-looking solutions designed for today’s dynamic clinical development landscape.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Getty-1652511983-supply-chain-management]( "A Custom IRT System Facilitates Precision Medicine Studies")
A Custom IRT System Facilitates Precision Medicine StudiesAs the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![Risk Management-GettyImages-665231256]( "Flexible Integrations To Reduce Risks And Increase Efficiencies")
Flexible Integrations To Reduce Risks And Increase EfficienciesLearn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
![Sales Advice Data Analytics]( "Complex Randomization Delivered Successfully")
Complex Randomization Delivered SuccessfullyLearn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
![iStock-635767756-clinical-trial-research]( "Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain")
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply ChainFlexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
![iStock-1288879010-gloves-mask-box]( "5 Common Clinical Supply Chain Speedbumps")
5 Common Clinical Supply Chain SpeedbumpsClinical trials can be very complex. Discover the need to connect planning and oversight from sourcing to shipping, along with mastering requirements such as cold chain, border slowdowns, and data privacy.
-
![iStock-1214764688-scientist-lab-analyze-research]( "Global Clinical Supply Solutions For Every Trial")
Global Clinical Supply Solutions For Every TrialA reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive strategy and manage day-to-day activities.
-
![Getty-1652511983-supply-chain-management]( "The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems")
The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented SystemsHere we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.
-
![GettyImages-1391646149 technology]( "Providing Drug Supply Support In Complex Environments Through IRT")
Providing Drug Supply Support In Complex Environments Through IRTLearn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
![GettyImages-1331571740-supply-chain-sourcing-logistics-tracking]( "The Dual Sourcing Approach")
The Dual Sourcing ApproachHaving a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
